| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/03/2014 | US20140186515 Dual drug dosage forms with improved separation of drugs |
| 07/03/2014 | US20140186514 Delayed release rasagiline formulation |
| 07/03/2014 | US20140186472 Composition and method for improving gastrointestinal health of equine |
| 07/03/2014 | US20140186471 Composition for inhibition of cathepsin k |
| 07/03/2014 | US20140186470 Compositions |
| 07/03/2014 | US20140186469 Pyrrolidine-1,2-dicarboxamide derivatives |
| 07/03/2014 | US20140186467 Composition and use for eradication of hiv, treatment of aids and other diseases including tuberculosis in a human |
| 07/03/2014 | US20140186466 Neutraceutical formulation for treatment of diabetes |
| 07/03/2014 | US20140186464 Prophylactic agent and/or therapeutic agent for sepsis |
| 07/03/2014 | US20140186459 Compositions and methods for forming and strengthening bone |
| 07/03/2014 | US20140186456 Tripartite Bioactive Composition Providing Anti-Oxidant and Anti-Inflammatory Effects with Immune System and Stem Cell Production Enhancement |
| 07/03/2014 | US20140186454 Dha and epa in the reduction of oxidative stress |
| 07/03/2014 | US20140186453 Therapeutic Polymeric Nanoparticles with mTOR Inhibitors and Methods of Making and Using Same |
| 07/03/2014 | US20140186452 Process for Preparing Therapeutic Nanoparticles |
| 07/03/2014 | US20140186450 Gastroresistant pharmaceutical formulations containing rifaximin |
| 07/03/2014 | US20140186449 Controlled release preparation |
| 07/03/2014 | US20140186448 Controlled release preparation |
| 07/03/2014 | US20140186447 Nanoparticle compositions of albumin and paclitaxel |
| 07/03/2014 | US20140186444 Drug formulations having improved pharmacokinetic properties |
| 07/03/2014 | US20140186443 Cyclodextrin nanotechnology for ophthalmic drug delivery |
| 07/03/2014 | US20140186442 Topical Minocycline Compositions and Methods of Using the Same |
| 07/03/2014 | US20140186440 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
| 07/03/2014 | US20140186439 Stable compositions of famotidine and ibuprofen |
| 07/03/2014 | US20140186438 Compositions comprising epa and obeticholic acid and methods of use thereof |
| 07/03/2014 | US20140186437 Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats |
| 07/03/2014 | US20140186435 Soluble tumor necrosis factor receptor (stnf-r) used as a targeting agent to treat arthritis and other diseases |
| 07/03/2014 | US20140186434 Anti-tumor necrosis factor alpha (tnf-a) antibody used as a targeting agent to treat arthritis and other diseases |
| 07/03/2014 | US20140186430 Cochleate compositions directed against expression of proteins |
| 07/03/2014 | US20140186428 Patch and method for producing the same |
| 07/03/2014 | US20140186424 Multi-polymer compositions for transdermal drug delivery |
| 07/03/2014 | US20140186422 Propynylaminoindan transdermal compositions |
| 07/03/2014 | US20140186421 Extended buprenorphine transdermal delivery compositions and methods for using the same |
| 07/03/2014 | US20140186420 Drug cores for sustained release of therapeutic agents |
| 07/03/2014 | US20140186416 Method for repairing or replacing damaged tissue |
| 07/03/2014 | US20140186408 Crystal polymorph of magnesium glycinate dihydrate and process for its preparation |
| 07/03/2014 | US20140186407 C-Met Modulator Pharmaceutical Compositions |
| 07/03/2014 | US20140186406 Treatment of Infection |
| 07/03/2014 | US20140186404 Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione in combination with antibodies |
| 07/03/2014 | US20140186400 Methods and compositions for treating autoimmune diseases |
| 07/03/2014 | US20140186377 Prostaglandin e2 binding proteins and uses thereof |
| 07/03/2014 | US20140186375 Combination of Immuno Gene Therapy and Chemotherapy for Treatment of Cancer and Hyperproliferative Diseases |
| 07/03/2014 | US20140186374 Manipulation of regulatory t cell and dc function by targeting neuritin gene using antibodies, agonists and antagonists |
| 07/03/2014 | US20140186368 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES |
| 07/03/2014 | US20140186367 Methods and compositions related to glucocorticoid receptor antagonists and breast cancer |
| 07/03/2014 | US20140186356 Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer |
| 07/03/2014 | US20140186347 Extending time to disease progression or survival in cancer patients |
| 07/03/2014 | US20140186345 Method of administering an antibody |
| 07/03/2014 | US20140186341 Methods for improving drug efficacy |
| 07/03/2014 | US20140186336 Methods of treating pterygium |
| 07/03/2014 | US20140186335 Certain Compounds, Compositions and Methods |
| 07/03/2014 | US20140186329 Polyphenol analogs to treat ischemia |
| 07/03/2014 | US20140186328 Neuroprotective polyphenol analogs |
| 07/03/2014 | US20140186322 Volatile Distillate By-Product of Mint Oil That Promotes Absorption and/or Bioavailability of Compounds of Bio-Medical and Nutritional Interest |
| 07/03/2014 | US20140186321 Method for Treating Metabolic Syndrome and Diabetes Using Quercetin and Bauhinia fortificata Extract |
| 07/03/2014 | US20140186306 Novel ampk agonist compositions and methods of use |
| 07/03/2014 | US20140186302 Nutritional Formulations and Method for Treating Diseases |
| 07/03/2014 | US20140186299 Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors |
| 07/03/2014 | US20140186296 Methods for Treatment of HIV and Other Infections Using a T-Cell or Viral Activator and Anti-Retroviral Combination Therapy |
| 07/03/2014 | US20140186295 Methods and compositions for the treatment of cancer |
| 07/03/2014 | US20140186291 Chemically Modified Dendrimers |
| 07/03/2014 | US20140186290 Nanoparticle based therapy for dispersing mucin |
| 07/03/2014 | US20140186289 Cyanoacrylate Tissue Adhesives with Desirable Permeability and Tensile Strength |
| 07/03/2014 | US20140186288 Co-Therapy for Diabetic Conditions |
| 07/03/2014 | US20140186287 Ingestible formulations for transient, noninvasive reduction of gastric volume |
| 07/03/2014 | US20140186279 Topical bioadhesive formulations |
| 07/03/2014 | US20140186278 Anhydrous multiphase gel system |
| 07/03/2014 | US20140186277 Methods and Compositions for Reducing Skin Damage |
| 07/03/2014 | US20140186266 Conjugates of nitroimidazoles and their use as chemotherapeutic agents |
| 07/03/2014 | US20140186261 Anti-tumor agent and anti-tumor kit |
| 07/03/2014 | US20140182597 Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol |
| 07/03/2014 | US20140182585 Aerosol container for foamable compositions |
| 07/03/2014 | DE102013107025A1 Methoden und zusammensetzungen zur behanldung von diabetis Methods and compositions for behanldung of diabetis |
| 07/03/2014 | DE102012113098A1 Monolithic dosage form, useful in a therapy for treating e.g. pain, psychiatric disorders, cardiovascular diseases, migraine and vertigo of any genesis, comprises first and active ingredients, an emulsifier, and a retarding agent |
| 07/02/2014 | EP2749641A1 Cancer stem cell isolation |
| 07/02/2014 | EP2749562A1 Fused heterocyclic derivative and pharmaceutical use thereof |
| 07/02/2014 | EP2749561A1 Radioactive quinolinone derivative and pharmaceutical drug comprising the same |
| 07/02/2014 | EP2749559A1 5-substituted isoindoline compounds |
| 07/02/2014 | EP2749558A1 Method for producing optically active naphthalene compound |
| 07/02/2014 | EP2749556A1 An improved process for the preparation of pure cyamemazine and salts thereof |
| 07/02/2014 | EP2749554A2 2,5-disubstituted arylsulfonamide CCR3 antagonists |
| 07/02/2014 | EP2749298A1 A 1,4,5-TRISUBSTITUTED1,2,3-TRIAZOLE MIMETIC OF RGD and/or OGP10-14, PROCESS TO OBTAIN IT AND USES THEREOF |
| 07/02/2014 | EP2749295A1 Radiopharmaceutical and pharmaceutical kit |
| 07/02/2014 | EP2749294A1 Anti-tumor agent and anti-tumor kit |
| 07/02/2014 | EP2749293A1 Polymer composition and polymer material |
| 07/02/2014 | EP2749286A1 Use of non-steroidal anti-inflammatory drugs meloxicam and piroxicam, administered intravaginally, for interruption of a woman's ovulation process |
| 07/02/2014 | EP2749285A1 Osteogenesis promoter and use thereof |
| 07/02/2014 | EP2749284A2 Combination of glycopyrronium and carmoterol |
| 07/02/2014 | EP2749283A2 Combination of glycopyrronium and olodaterol |
| 07/02/2014 | EP2749282A1 Method of treating atrial fibrillation |
| 07/02/2014 | EP2749281A1 Prophylactic/therapeutic agent for cardiovascular complications of diabetes |
| 07/02/2014 | EP2749280A2 Combination of glycopyrronium and formoterol |
| 07/02/2014 | EP2749279A1 Hydrous adhesive skin patch |
| 07/02/2014 | EP2749278A1 Gestagen combination and an insulin sensitizer for treating PCOS |
| 07/02/2014 | EP2749277A2 Combination of glycopyrronium and vilanterol |
| 07/02/2014 | EP2749276A1 Use of patchouli alcohol in preparation of drug against helicobacter pylori |
| 07/02/2014 | EP2749275A1 Method for preparing metered dose sprayed inhaler for treating respiratory disease |
| 07/02/2014 | EP2749274A1 Patch comprising oxybutynin hydrochloride and method for producing the same |
| 07/02/2014 | EP2749273A1 Solid oral preparation with modified release |
| 07/02/2014 | EP2749271A1 Optimized manufacturing method and pharmaceutical formulation of imatinib |
| 07/02/2014 | EP2749270A1 Racecadotril and pharmaceutical compositions thereof |